Consensus Radiopharm Theranostics Limited

Equities

RAD

AU0000181851

Market Closed - Australian S.E. Other stock markets 01:56:11 2024-05-03 EDT			5-day change	1st Jan Change
0.04 ^AUD	+11.11%		-13.04%	-45.95%

02-29	Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study	MT
02-29	Radiopharm Theranostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Evolution of the average Target Price on Radiopharm Theranostics Limited

Price target over the last 5 years

History of analyst recommendation changes

b111fa8b0644744767d40644.1-CM7O9Ul7rRZNimMzzZ9IpItzWcd92EewrVSqlQ5S4.5pfUvNtn4-m1Vu35ckqOubo43A2tOK69TDrhH8Edt0qQ2cKtjQvmiYcejQ~7be956c5c0bfb26de838b69d704452f4

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.0235 USD

Average target price

0.317 USD

Spread / Average Target

+1,246.11%

High Price Target

0.462 USD

Spread / Highest target

+1,861.83%

Low Price Target

0.172 USD

Spread / Lowest Target

+630.38%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar